Page last updated: 2024-10-17

cytosine and Keratoconjunctivitis

cytosine has been researched along with Keratoconjunctivitis in 7 studies

Keratoconjunctivitis: Simultaneous inflammation of the cornea and conjunctiva.

Research Excerpts

ExcerptRelevanceReference
"2% cidofovir eyedrops and 1% cyclosporine eyedrops administered 4 times daily (qid) to treat acute adenoviral keratoconjunctivitis."9.09Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. ( Böhringer, D; Cartsburg, O; De Clercq, E; Godehardt, E; Hillenkamp, J; Reinhard, T; Roggendorf, M; Ross, RS; Sundmacher, R, 2001)
"2% cidofovir eyedrops and 1% cyclosporine eyedrops administered 4 times daily (qid) to treat acute adenoviral keratoconjunctivitis."5.09Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. ( Böhringer, D; Cartsburg, O; De Clercq, E; Godehardt, E; Hillenkamp, J; Reinhard, T; Roggendorf, M; Ross, RS; Sundmacher, R, 2001)
" Further clinical studies to find an efficacious yet tolerable dosage regimen of cidofovir, possibly using an improved pharmaceutical preparation, are required."2.70The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. ( Böhringer, D; Cartsburg, O; De Clercq, E; Godehardt, E; Hillenkamp, J; Reinhard, T; Roggendorf, M; Ross, RS; Sundmacher, R, 2002)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's1 (14.29)18.2507
2000's4 (57.14)29.6817
2010's0 (0.00)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Hanaoka, N1
Hazama, M1
Fukushima, K1
Fujimoto, T1
Nwanegbo, EC1
Romanowski, EG3
Gordon, YJ3
Gambotto, A1
Araullo-Cruz, T1
Hillenkamp, J2
Reinhard, T2
Ross, RS2
Böhringer, D2
Cartsburg, O2
Roggendorf, M2
De Clercq, E2
Godehardt, E2
Sundmacher, R2
Segal, E1
Romano, A1
Eylan, E1
Stein, R1

Trials

2 trials available for cytosine and Keratoconjunctivitis

ArticleYear
Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2001, Volume: 119, Issue:10

    Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Adult; Ag

2001
The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
    Ophthalmology, 2002, Volume: 109, Issue:5

    Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Adult; Aged; Aged, 80 and over; An

2002

Other Studies

5 other studies available for cytosine and Keratoconjunctivitis

ArticleYear
Sensitivity of Human Mastadenovirus, the Causal Agent of Pharyngoconjunctival Fever, Epidemic Keratoconjunctivitis, and Hemorrhagic Cystitis in Immunocompromised Individuals, to Brincidofovir.
    Microbiology spectrum, 2022, 02-23, Volume: 10, Issue:1

    Topics: Adenoviridae Infections; Adenovirus Infections, Human; Cystitis; Cytosine; Humans; Immunocompromised

2022
Efficacy of topical immunoglobulins against experimental adenoviral ocular infection.
    Investigative ophthalmology & visual science, 2007, Volume: 48, Issue:9

    Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agent

2007
Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
    Investigative ophthalmology & visual science, 1994, Volume: 35, Issue:12

    Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Cidofovir; Cytosine; Eye In

1994
Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model.
    Investigative ophthalmology & visual science, 2000, Volume: 41, Issue:2

    Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agent

2000
Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections.
    Chemotherapy, 1975, Volume: 21, Issue:6

    Topics: Animals; Candida; Candidiasis; Conjunctivitis; Corneal Ulcer; Cytosine; Drug Resistance, Microbial;

1975